"NORDPHARM POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI

TAX ID1132179195

KRS0000052953

Share capital50,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

AL. JEROZOLIMSKIE 99 / 39, 02-001 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

"NORDPHARM POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

AL. JEROZOLIMSKIE 99 / 39, 02-001 WARSZAWA

Show on map

NIP

1132179195

REGON

016112637

KRS

0000052953

Legal form

limited liability company

Register Address

AL. JEROZOLIMSKIE 99 / 39, 02-001 WARSZAWA

Date of registration in KRS

2001-10-19

Date of commencement of economic activity

2001-10-19

Act signature

RDF/713152/25/830

Pkd codes

43.99.Z - Other specialized construction works, not classified elsewhere

10.91.Z - Production of prepared animal feed for livestock

10.92.Z - Production of prepared pet food

21.10.Z - Manufacture of basic pharmaceutical products

43.21.Z - Installation of electrical systems

43.22 - Installation of plumbing, heating, and air-conditioning systems

43.29.Z - Specialized construction works

43.31.Z - Plastering

43.34 - Painting and glazing

Payer VAT status

Active

Vat list bank account(s)

PL75 1090 1043 0000 0000 0501 0327

Company authorities

shareholders

NORDVET APS

100% 50 udziałów o łącznej wysokości 50.000 pln

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	K PLN	K PLN	K PLN	%
Gross profit (loss)	141,3	158,7	-79,6	-150,1
EBITDA	145,5	174,2	-77,8	-144,7
Short time liabilities	0,6	1,5	1,7	13,4
Equity capital	264,1	408,4	328,8	-19,5
Operating profit (EBIT)	145,5	174,2	-77,8	-144,7
Assets	264,6	409,9	330,5	-19,4
Net profit (loss)	92	144,3	-79,6	-155,1
Cash	241,1	398,2	324,3	-18,6
Liabilities and provisions for liabilities	0,6	1,5	1,7	13,4
Net income from sale	508,4	747,6	0	-100
Working assets	264,6	409,9	330,5	-19,4
Depreciation	0	0	0	0
	%	%	%	p.p.
Profitability of capital	34,8	35,3	-24,2	-59,5
Equity capital to total assets	99,8	99,6	99,5	-0,1
Gross profit margin	27,8	21,2		-6,6
EBITDA Margin	28,6	23,3		-5,3
	Days	Days	Days	Days
Short term commitment turnover cycle	0	1	2 147 483 648	2 147 483 647

Current financial liquidity indicator	477.6230163574219	269.92645263671875	191.8911590576172	-78
Net dept to EBITDA	-1.6565301418304443	-2.286275625228882	4.168372631072998	6,5